[1] Amako Y, Tsukiyama-Kohara K, Katsume A, Hirata Y, Sekiguchi S, Tobita Y, et al. 2010. Pathogenesis of hepatitis C virus infection in Tupaia belangeri. Journal of Virology, 84(1): 303−311. doi:  10.1128/JVI.01448-09
[2] Bao LL, Deng W, Huang BY, Gao H, Liu JN, Ren LL, et al. 2020. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. doi:  10.1038/s41586-020-2312-y.
[3] Chan JFW, Zhang AJ, Yuan SF, Poon VKM, Chan CCS, Lee ACY, et al. 2020. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clinical Infectious Diseases. doi:  10.1093/cid/ciaa325.
[4] Duan K, Liu BD, Li CS, Zhang HJ, Yu T, Qu JM, et al. 2020. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America, 117(17): 9490−9496. doi:  10.1073/pnas.2004168117
[5] Fan Y, Ye MS, Zhang JY, Xu L, Yu DD, Gu TL, et al. 2019. Chromosomal level assembly and population sequencing of the Chinese tree shrew genome. Zoological Research, 40(6): 506−521. doi:  10.24272/j.issn.2095-8137.2019.063
[6] Gao Q, Bao LL, Mao HY, Wang L, Xu KW, Yang M, et al. 2020. Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369(6499): 77−81. doi:  10.1126/science.abc1932
[7] Geleris J, Sun YF, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. 2020. Observational study of hydroxychloroquine in hospitalized patients with COVID-19. The New England Journal of Medicine, 382(25): 2411−2418. doi:  10.1056/NEJMoa2012410
[8] Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. 2020. Remdesivir for 5 or 10 days in patients with severe COVID-19. The New England Journal of Medicine. doi:  10.1056/NEJMoa2015301.
[9] Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. 2020. Compassionate use of remdesivir for patients with severe COVID-19. The New England Journal of Medicine, 382(24): 2327−2336. doi:  10.1056/NEJMoa2007016
[10] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18): 1708−1720. doi:  10.1056/NEJMoa2002032
[11] Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, et al. 2020. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe, 27(5): 704−709.e2. doi:  10.1016/j.chom.2020.03.023
[12] Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, et al. 2020. Outcomes of 3, 737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Medicine and Infectious Disease. doi:  10.1016/j.tmaid.2020.101791.
[13] Lam TTY, Jia N, Zhang YW, Shum MHH, Jiang JF, Zhu HC, et al. 2020. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. doi:  10.1038/s41586-020-2169-0.
[14] Li LH, Li ZR, Wang EL, Yang R, Xiao Y, Han HB, et al. 2016. Herpes simplex virus 1 infection of tree shrews differs from that of mice in the severity of acute infection and viral transcription in the peripheral nervous system. Journal of Virology, 90(2): 790−804. doi:  10.1128/JVI.02258-15
[15] Li RF, Zanin M, Xia XS, Yang ZF. 2018. The tree shrew as a model for infectious diseases research. Journal of Thoracic Disease, 10(Suppl 19): S2272−S2279.
[16] Lu RJ, Zhao X, Li J, Niu PH, Yang B, Wu HL, et al. 2020a. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224): 565−574. doi:  10.1016/S0140-6736(20)30251-8
[17] Lu SY, Zhao Y, Yu WH, Yang Y, Gao JH, Wang JB, et al. 2020b. Comparison of SARS-CoV-2 infections among 3 species of non-human primates. bioRxiv. doi:  10.1101/2020.04.08.031807.
[18] Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, et al. 2020. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Medicine and Infectious Disease, 35: 101738. doi:  10.1016/j.tmaid.2020.101738
[19] Munster VJ, Feldmann F, Williamson BN, van Doremalen N, Pérez-Pérez L, Schulz J, et al. 2020. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. doi:  10.1038/s41586-020-2324-7.
[20] Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology, 27(3): 493−497. doi:  10.1093/oxfordjournals.aje.a118408
[21] Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, et al. 2020. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science, 368(6494): 1012−1015. doi:  10.1126/science.abb7314
[22] Shan C, Yao YF, Yang XL, Zhou YW, Gao G, Peng Y, et al. 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in rhesus macaques. Cell Research. doi:  10.1038/s41422-020-0364-z.
[23] Shi JZ, Wen Z, Zhong GX, Yang HL, Wang C, Huang BY, et al. 2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science, 368(6494): 1016−1020. doi:  10.1126/science.abb7015
[24] Tang W, Cao ZJ, Han MF, Wang ZY, Chen JW, Sun WJ, et al. 2020. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ: British Medical Journal, 369: m1849.
[25] Wang DW, Hu B, Hu C, Zhu FF, Liu X, Zhang J, et al. 2020a. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. doi:  10.1001/jama.2020.1585.
[26] Wang ML, Cao RY, Zhang LK, Yang XL, Liu J, Xu MY, et al. 2020b. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3): 269−271. doi:  10.1038/s41422-020-0282-0
[27] Wang Q, Schwarzenberger P, Yang F, Zhang JJ, Su JJ, Yang C, et al. 2012. Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans. Virology Journal, 9: 170. doi:  10.1186/1743-422X-9-170
[28] Wang YM, Zhang DY, Du GH, Du RH, Zhao JP, Jin Y, et al. 2020c. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet, 395(10236): 1569−1578. doi:  10.1016/S0140-6736(20)31022-9
[29] Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, et al. 2020. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. doi:  10.1038/s41586-020-2423-5.
[30] Wong G, Bi YH, Wang QH, Chen XW, Zhang ZG, Yao YG. 2020. Zoonotic origins of human coronavirus 2019 (HCoV-19/SARS-CoV-2): why is this work important?. Zoological Research, 41(3): 213−219. doi:  10.24272/j.issn.2095-8137.2020.031
[31] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579(7798): 265−269. doi:  10.1038/s41586-020-2008-3
[32] Xiao J, Liu R, Chen CS. 2017. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model. Zoological Research, 38(3): 127−137. doi:  10.24272/j.issn.2095-8137.2017.033
[33] Xiao KP, Zhai JQ, Feng YY, Zhou N, Zhang X, Zou JJ, et al. 2020. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature, 583(7815): 286−289. doi:  10.1038/s41586-020-2313-x
[34] Xu S, Li XY, Yang JY, Wang ZX, Jia Y, Han L, et al. 2019. Comparative pathogenicity and transmissibility of pandemic H1N1, avian H5N1, and human H7N9 influenza viruses in tree shrews. Frontiers in Microbiology, 10: 2955. doi:  10.3389/fmicb.2019.02955
[35] Xu XL, Han MF, Li TT, Sun W, Wang DS, Fu BQ, et al. 2020. Effective treatment of severe COVID-19 patients with tocilizumab. Proceedings of the National Academy of Sciences of the United States of America, 117(20): 10970−10975. doi:  10.1073/pnas.2005615117
[36] Yang XB, Yu Y, Xu JQ, Shu HQ, Xia JA, Liu H, et al. 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8(5): 475−481. doi:  10.1016/S2213-2600(20)30079-5
[37] Yao YG. 2017. Creating animal models, why not use the Chinese tree shrew (Tupaia belangeri chinensis)?. Zoological Research, 38(3): 118−126. doi:  10.24272/j.issn.2095-8137.2017.032
[38] Yu B, Li CZ, Chen P, Zhou N, Wang LY, Li J, et al. 2020a. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Science China Life Sciences. doi:  10.1007/s11427-020-1732-2.
[39] Yu P, Qi FF, Xu YF, Li FD, Liu PP, Liu JY, et al. 2020b. Age-related rhesus macaque models of COVID-19. Animal Models and Experimental Medicine, 3(1): 93−97. doi:  10.1002/ame2.12108
[40] Zhang C, Shi L, Wang FS. 2020a. Liver injury in COVID-19: management and challenges. The Lancet Gastroenterology & Hepatology, 5(5): 428−430.
[41] Zhang MX, Song TZ, Zheng HY, Wang XH, Lu Y, Zhang HD, et al. 2019. Superior intestinal integrity and limited microbial translocation are associated with lower immune activation in SIVmac239-infected northern pig-tailed macaques (Macaca leonina). Zoological Research, 40(6): 522−531. doi:  10.24272/j.issn.2095-8137.2019.047
[42] Zhang T, Wu QF, Zhang ZG. 2020b. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology, 30(7): 1346−1351.e2. doi:  10.1016/j.cub.2020.03.022
[43] Zhao Y, Wang JB, Kuang DX, Xu JW, Yang ML, Ma CX, et al. 2020. Susceptibility of tree shrew to SARS-CoV-2 infection. bioRxiv. doi:  10.1101/2020.04.30.029736.
[44] Zhou H, Chen X, Hu T, Li J, Song H, Liu YR, et al. 2020a. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein. Current Biology, 30(11): 2196−2203.e3. doi:  10.1016/j.cub.2020.05.023
[45] Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. 2020b. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798): 270−273. doi:  10.1038/s41586-020-2012-7
[46] Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. 2020. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8): 727−733. doi:  10.1056/NEJMoa2001017